These findings were corroborated at the protein level: Western blotting confirmed lower TMEM59L expression in tumor tissues relative to normal tissues, while immunohistochemical staining revealed a pronounced increase in TMEM59L expression in distant metastases compared to primary tumor samples (Figure 1E,F). The gene discussed is TMEM59L; the disease is neoplasm.